Which anti-beclin-1 antibody was used and how was it validated in canine tissues?

• A. Rabbit polyclonal anti-beclin-1 at 1:100; Validated by ELISA
• B. Mouse monoclonal anti-beclin-1 at 1:300 dilution; Validated in canine tissues via western blot
• C. Mouse monoclonal anti-beclin-1 at 1:50; Validated by immunofluorescence
• D. Goat polyclonal anti-beclin-1 at 1:250; Validated by qPCR

Answer: (B)

The main idea is confirming that an antibody truly recognizes the canine Beclin-1 protein in tissue, and doing so with a method that proves specificity and correct molecular weight in dog samples. A mouse monoclonal antibody against Beclin-1 used at a 1:300 dilution provides high specificity because a monoclonal binds a single epitope, reducing cross‑reactivity. Validating in canine tissues with a Western blot shows a band at the expected molecular weight for Beclin-1 in dog tissue lysates, confirming that the antibody binds the canine protein and behaves consistently in the species of interest. This kind of tissue-based protein validation is robust evidence of usefulness for downstream applications in dogs.

The other approaches are less ideal for establishing that the antibody works specifically in canine tissue. A rabbit polyclonal antibody, while useful, carries more risk of cross-reactivity and variable affinity. Validation by ELISA tests binding to antigen in a soluble or purified form, not the protein’s native context in tissue. A smaller dilution for a monoclonal could be fine, but the critical point is the tissue-based Western blot confirmation. A qPCR approach validates RNA, not protein, so it doesn’t directly demonstrate antibody performance for Beclin-1 protein in dog tissues, and immunofluorescence alone, while informative, doesn’t by itself confirm the correct molecular weight and specificity in a tissue lysate.